Safi Biotherapeutics

Cambridge, Massachusetts, United States · Biotechnology, Health Care, Manufacturing · 11 employees

Safi Biotherapeutics is a developer of manufactured red blood cells (mRBCs) designed to serve as an alternative to donor blood transfusions. The company is focused on advancing bio-manufactured red blood cells with targeted immuno-phenotypes for various chronic transfusion indications. Launched in 2020, Safi is progressing the technology to demonstrate the feasibility of an allogeneic, stem-cell s

See plans & pricing → Track Safi Biotherapeutics’s funding, hiring, and signals — with verified contacts — on Fundz.